SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Clinical trials for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells target lupus in early trial
Disease control Not yet recruitingThis study tests a new treatment called BCMA-CD19-IL-15 cCAR T for people with severe lupus that hasn't improved with standard therapies. The treatment uses a person's own immune cells, modified to attack lupus-causing cells. The goal is to reduce disease activity and possibly al…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Phase: PHASE1, PHASE2 • Sponsor: iCell Gene Therapeutics • Aim: Disease control
Last updated Apr 29, 2026 09:46 UTC
-
Hidden lupus: study aims to uncover why some patients are misdiagnosed
Knowledge-focused Not yet recruitingThis study looks at 400 people with lupus to compare those with typical symptoms versus those with unusual or 'atypical' symptoms. Atypical lupus can be harder to diagnose and may lead to worse health outcomes. Researchers will track disease activity and organ damage over time to…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Apr 29, 2026 09:48 UTC